Doha, Qatar: To mark World Cancer Research Day and Childhood Cancer Awareness Month, Sidra Medicine, a member of Qatar Foundation, has published its ‘Paediatric Oncology Report 2023’. This year’s report presents information on the treatment modalities employed at Sidra Medicine and the remarkable outcomes achieved for its young patients. It also takes a deeper dive by exploring the specifics of leukaemia and brain tumours, going beyond previous reporting of solid and non-solid cancers statistics.
The report offers an analysis of paediatric cancer types treated at the hospital, with a clear distinction between solid cancers (69 percent) and non-solid cancers (31 percent). Regarding patient demographics, the majority are of Arab descent (60 percent), followed by Asian patients (32 percent). The remaining less than 10 percent represent other ethnicities.
Among the diagnoses, Leukemia emerges as the most frequent at 31 percent, closely followed by Central Nervous System malignancies at 23 percent. Dr. Ayman Saleh, Division Chief of Haematology and Oncology at Sidra Medicine said: “This report is more than just data.
It is a roadmap that helps us navigate the epidemiology of childhood cancer in Qatar. By understanding the types of cancers affecting our children, the effectiveness of our treatments, and the ongoing research advancements, we can work together to provide the best possible outcomes. Our impressive survival rate of almost 90 percent between 2019 and 2023 surpas.
